Active	Status	Sponsor type	Region	Phase	Filter
3 Active 6 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Viberzi (eluxadoline) / AbbVie
NCT04880876: A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)	Enrolling by invitation	3	124	US	25mg Eluxadoline, 100mg Eluxadoline	AbbVie	Irritable Bowel Syndrome	03/27	03/27
NCT04313088: Investigation of Eluxadoline for Diabetic Diarrhea	Withdrawn	2/3	24	US	Eluxadoline 100 mg, Viberzi	Temple University, Allergan	Diabetic Diarrhea, Diabetes, Diarrhea	12/23	12/24
NCT03339128 / 2017-003770-14: Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children	Recruiting	2	95	Europe, Canada, US	Eluxadoline, Viberzi, Placebo	AbbVie	Irritable Bowel Syndrome	12/26	12/26

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Viberzi (eluxadoline) / AbbVie
NCT04880876: A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)	Enrolling by invitation	3	124	US	25mg Eluxadoline, 100mg Eluxadoline	AbbVie	Irritable Bowel Syndrome	03/27	03/27
NCT04313088: Investigation of Eluxadoline for Diabetic Diarrhea	Withdrawn	2/3	24	US	Eluxadoline 100 mg, Viberzi	Temple University, Allergan	Diabetic Diarrhea, Diabetes, Diarrhea	12/23	12/24
NCT03339128 / 2017-003770-14: Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children	Recruiting	2	95	Europe, Canada, US	Eluxadoline, Viberzi, Placebo	AbbVie	Irritable Bowel Syndrome	12/26	12/26